Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.

First world conference on luteinizing hormone in ART: Landing in Asia Pacific

First world conference on luteinizing hormone in ART: Landing in Asia Pacific
  • Reproductive medicine
  • Fertility
Regional conference by Excemed
Saturday, Nov 19 - Sunday, Nov 20 2016
Bangkok, Thailand

Accreditation

EACCME®

Language

English

Registration status
Closed

To register for this event, contact

Meridiano Congress International (Italy)
Project Manager: Giorgia Di Egidio
T +39 06 88 595 232 - F +39 06 88595 234
giorgia.diegidio@meridiano.it

Registration fee

230.00€

The registration fee is 230€ and includes:
•    Scientific sessions
•    Coffee breaks and luncheons
•    Dinner on November 19, 2016
•    Educational materials
•    Certificate of attendance

Introduction

Access resources by clicking the Outcomes tab or by scrolling down to the Scientific Programme.

Overview

This conference will review and further enlighten the main topics discussed during the First world conference on luteinizing hormone (LH) in ART: A flight of discovery in Naples, Italy on 27-28 May 2016. The role of LH during folliculogenesis has heightened curiosity for at least three decades. In particular, the scientific community is still divided over recognizing the relevance of LH containing drugs during controlled ovarian stimulation (COS). Availability of recombinant drugs has offered, for the first time, the opportunity to explore the role of the follicle  stimulating hormone (FSH) and LH separately. Despite the opportunity, the role of recombinant LH is still a matter of debate. This conference will show evidence from basic science to clinical practice regarding the use of  recombinant LH and will illustrate its possible benefits  as well as its physiopathological mechanism. Guided by  an expert, participants will grasp the rationale for using recombinant LH in assisted reproductive technology as well as understand the role of LH in human reproduction.

Learning objectives

  • Understand the physiology of LH and its role in ovulation induction
  • Grasp the state of the art regarding the use of recombinant LH
  • Individualise  groups  of  patients  that  required  LH  during stimulation protocols
  • Identify  specific  ovarian  reserve  markers  and  genotype polymorphisms useful for tailoring treatments and choosing the best approach

Accreditation details

EXCEMED (www.excemed.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ® ) to provide  the  following  CME  activity  for  medical  specialists.  The  EACCME ® is  an  institution  of  the  European  Union  of  Medical Specialists (UEMS), www.uems.net


The CME workshop “First world conference on luteinizing hormone in ART: Landing in Asia Pacific” held on 19-20 November 2016 in Bangkok, Thailand, is designated for a maximum of 6 (six) hours of European CME credits (ECMEC). Each medical specialist should claim only those  credits  that  he/she  actually  spent  in  the  educational  activity.  EACCME ® credits  are  recognized  by  the  American  Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.

Scientific programme

Saturday, 19 November 2016

From 12.00 Registration

                      Welcome lunch


14.00     Opening and introduction, R. Fischer (Germany)

Session I: A long runway: Impaired outcome in IVF

 
14.10  L1  The history of POR: it is time to turn the page?  Video lecture, S. C. Esteves (Brazil)


14.35  L2   Ovarian reserve, euploidy rates and ovarian sensitivity: three actors for one movie Video lecture, C. Alviggi (Italy)


15.00  L3  From POR to low prognosis concept: a new proposed stratification by POSEIDON Working Group Video lecture, P. Humaidan (Denmark)


15.25    Coffee break


15.45    Case studies


16.15    Panel discussion


17.00    End of the first day

Sunday, 20 November 2016

08.30         Wrap up

Session II The in-flight movies: "Is too much better than not enough?"

08.45  L4   How many oocytes are needed for one euploid embryo? Video lecture, S. C. Esteves (Brazil)


09.10  L5   COS strategies to increase oocyte number/quality Video lecture,  P. Humaidan (Denmark)


09.35  L6   DuoStim: the alternative of oocytes/embryos accumulation programs, C. Alviggi (Italy)   


10.00   Case studies


10.30   Panel discussion


11.00   Coffee break

Session III: Landing in the real LH world

11.15  L7   The rationale for the use of LH during COS: from basic science to clinical practice Video lecture, S. C. Esteves (Brazil)


11.40  L8   Which POSEIDON groups may benefit of LH supplementation? Video lecture, C. Alviggi (Italy)


12.05  L9   What about personalized luteal phase support? Video lecture, P. Humaidan (Denmark)


12.30   Case studies


13.00    Panel discussion


13.30    Concluding remarks


13.45    End of the conference

              Closing lunch

CME provider

EXCEMED - Excellence in Medical Education

Senior Programme Manager: Chloé Xilinas
T +39 06 420413 505 - F +39 06 420413 677
chloe.xilinas@excemed.org
Medical Advisor: Alessandro Conforti
confale@hotmail.it

Chair(s)

Sandro Esteves

ANDROFERT - Andrology & Human Reproduction Clinic
Campinas, Brazil

Peter Humaidan

Skive Regional Hospital and Faculty of Health
Aarhus University
Fertility Clinic
Skive, Denmark
Slide kit
Carlo Alviggi
Reproductive medicine
Slide kit
Carlo Alviggi
Reproductive medicine
Sandro Esteves
Reproductive medicine
Slide kit
Sandro Esteves
Reproductive medicine
Slide kit
Sandro Esteves
Reproductive medicine
Peter Humaidan
Reproductive medicine
Slide kit
Peter Humaidan
Reproductive medicine
Slide kit
Peter Humaidan
Reproductive medicine
Slide kit
Peter Humaidan
Reproductive medicine